Advertisement
Canada markets open in 5 hours 16 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7333
    +0.0010 (+0.13%)
     

  • CRUDE OIL

    84.02
    +0.45 (+0.54%)
     

  • Bitcoin CAD

    87,830.80
    +456.37 (+0.52%)
     

  • CMC Crypto 200

    1,387.74
    -8.79 (-0.63%)
     

  • GOLD FUTURES

    2,359.00
    +16.50 (+0.70%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,758.75
    +191.25 (+1.09%)
     

  • VOLATILITY

    15.51
    +0.14 (+0.91%)
     

  • FTSE

    8,122.25
    +43.39 (+0.54%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6826
    +0.0005 (+0.07%)
     

Today's Research Reports on Crescita Therapeutics, Centric Health Corporation, Cipher Pharmaceuticals and Aralez Pharmaceuticals

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / October 16, 2017 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Crescita Therapeutics Inc.
https://rdinvesting.com/news/?ticker=CTX.TO

Centric Health Corporation
https://rdinvesting.com/news/?ticker=CHH.TO

Cipher Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=CPH.TO

Aralez Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=ARZ.TO

ADVERTISEMENT

Crescita Therapeutics Inc.'s stock jumped 9.33% Friday, to close the day at $0.82. The stock recorded a trading volume of 21,730 shares, which was above its three months average volume of 8,346 shares. In the last year Crescita Therapeutics Inc.'s shares have traded in a range of 0.53 - 1.70. The share price has gained 54.72% from its 52 week low. Shares of Crescita Therapeutics have fallen approximately 30.51 percent year-to-date.

Access RDI's Crescita Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CTX.TO

On Friday, shares in Centric Health Corporation recorded a trading volume of 31,400 shares, which was below the three months average volume of 212,129 shares. The stock ended the day 1.28% lower at 0.77. The share price has gained 120.00% from its 52 week low with a 52 week trading range of 0.35 - 0.91.The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.77 is greater than its 200-day moving average of $0.74. Shares of the company are trading at a Price to Earnings ratio of 96.25. Shares of Centric Health have gained approximately 30.51 percent year-to-date.

Access RDI's Centric Health Corporation Research Report at:
https://rdinvesting.com/news/?ticker=CHH.TO

Cipher Pharmaceuticals Inc.'s stock moved 2.05% higher Friday, to close the day at $4.49. The stock recorded a trading volume of 24,150 shares, which was above its three months average volume of 9,021 shares. In the last year Cipher Pharmaceuticals Inc.'s shares have traded in a range of 3.50 - 5.75. The share price has gained 28.29% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $4.74 is below its 200-day moving average of $5.06. Shares of Cipher Pharmaceuticals have fallen approximately 8.37 percent year-to-date.

Access RDI's Cipher Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CPH.TO

On Friday, shares in Aralez Pharmaceuticals Inc. recorded a trading volume of 163,495 shares, which was above the three months average volume of 65,308 shares. The stock ended the day 13.52% lower at 2.11. The share price has gained 75.83% from its 52 week low with a 52 week trading range of 1.20 - 7.35. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $2.32 is at its 200-day moving average of $2.32. Shares of Aralez Pharmaceuticals have fallen approximately 64.3 percent year-to-date.

Access RDI's Aralez Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ARZ.TO

Our Actionable Research on Crescita Therapeutics Inc. (TSX: CTX.TO), Centric Health Corporation (TSX: CHH.TO), Cipher Pharmaceuticals Inc. (TSX: CPH.TO) and Aralez Pharmaceuticals Inc. (TSX: ARZ.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com